MedPath

Study on reintroduction regimen of antituberculous therapy after developing of drug-induced hepatotoxicity (DIH)

Not Applicable
Conditions
tuberculosis
Registration Number
JPRN-UMIN000008069
Lead Sponsor
ational Center for Global Health and Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1)HIV infection 2)Pregnancy of breast-feeding 3)Liver cirrhosis 4)Acute or chronic hepatitis infection 5)Known resistance against INH or RFP 6)Persistent liver damage 7)Abnormal laboratory finding; WBC <2,000/mm3, Hgb <7g/dL, Platelet count <50,000/mm3 8)Patients whom the attending physician decided unsuitable for entering the present study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath